Search

everythinglearnresearchcommunity

for

Search:↓

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Using fat stem cells and blood cell-rich plasma together improves healing in diabetic wounds by affecting cell signaling.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

Hair aging is caused by stress, hormones, inflammation, and DNA damage affecting hair growth and color.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Herbal extracts and platelet-rich plasma together may help increase hair growth by making certain cells grow more, through specific cell growth pathways.

Skin fat helps with body temperature control and has other active roles in health.

Finasteride reduces alcohol withdrawal severity in male mice but increases it in female mice.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Freezing gamma-irradiated amniotic fluid may help hair growth and speed up the growth phase.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Mouse hair follicle cells briefly grow during the early hair growth phase, showing that these cells are important for starting the hair cycle.

Hair color production is closely linked to the active growth phase of hair in mice and may also influence hair growth itself.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Hair color production in mice is closely linked to the hair growth phase and may also influence hair growth itself.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Stress can worsen skin and hair conditions by affecting the skin's immune response and hormone levels.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Platelet Rich Plasma (PRP) shows promise for tissue repair and immune response, but more research is needed to fully understand it and optimize its use.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

Ketogenic diet, neurosteroids, and HMGB1-TLR4 signaling pathway are potential targets for new epilepsy treatments.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.